Hans Nordgren
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, BRCA gene mutations in cancer
Most-Cited Works
- → Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis(2006)2,125 cited
- → Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts(2005)832 cited
- → Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer(2006)757 cited
- → 10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial(1999)583 cited
- → FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer(2007)518 cited
- → The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry(1996)388 cited
- → SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening(2006)236 cited
- → HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review(2004)225 cited
- → Tumour markers in breast carcinoma correlate with grade rather than with invasiveness(2001)119 cited
- → EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases(2007)81 cited